This month we are talking about our new patient engagement service for the life sciences industry. Dr William van’t Hoff explains how the service is helping to balance the ‘ask’ of research with the burden of disease.
An NIHR-funded European study of nearly 1000 male couples has confirmed that effective antiretroviral therapy prevents HIV transmission, with no cases of transmission within couples over eight years of follow-up.
Research is the innovation that brings better healthcare and treatments to patients in the NHS and it is part of the NIHR’s role to ensure the talent pool of research active clinicians continues to thrive. The NIHR Clinical Research Network (CRN) Infection Specialty Group is helping do just that by making it a focus for their work.
The NIHR is supporting the world’s largest, most detailed study of sexual behaviour and wellbeing by joint funding the fourth wave of Britain’s National Surveys of Sexual Attitudes and Lifestyles (Natsal).
Patients with tuberculosis (TB) are more likely to continue their drug treatment if they are supported using smartphones rather than by attending face-to-face appointments, a new study funded by the NIHR has found.
Pills are just as effective as intravenous (IV) injections in tackling bone infections, a study published in The New England Journal of Medicine has found, raising hopes that patients could go home sooner and reduce NHS costs.
Providing clean injecting equipment through needle and syringe programmes is a highly cost-effective way of preventing hepatitis C (HCV) transmission among people who inject drugs and could save millions of pounds in infection treatment costs in the UK, according to NIHR-funded researchers.